Registration link: https://event.on24.com/wcc/r/3733481/EFB2A2A7B11C45A4E54B9C4296D87CB1?partnerref=tfslp
Summary
As respiratory testing grows in prevalence in light of the COVID-19 pandemic, there are considerations and challenges clinical labs and clinicians must deal with. How can a laboratory best implement syndromic testing for multiple respiratory diseases? What are the benefits of multiplex testing versus single-panel testing? What should a clinician know before ordering these tests? How can labs quickly address new SARS-CoV-2 variants that may arise? And what role does reimbursement play in clinical decision-making?
This virtual roundtable discussion will address these concerns and more with a panel of industry stakeholders from the US, Europe, and South Africa, who will discuss strategies for respiratory testing implementation in a world where COVID-19 is becoming endemic.
The session will include a live Q&A in which attendees can post questions to our panelists.